Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Blood Transplant for Severe Aplastic Anemia and Other Disorders
NCT00003336Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jan 1998
- Primary completion
- Dec 2005
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in aplastic anemia, myelodysplastic syndrome (MDS), Inborn errors of metabolism (IEM), inherited hematopoietic stem cell disorder, thymoma, sponsored by Case Comprehensive Cancer Center. Started Jan 1998; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
aplastic anemiamyelodysplastic syndrome (MDS)Inborn errors of metabolism (IEM)inherited hematopoietic stem cell disorderthymoma
Beyond the preview
Go deeper on NCT00003336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003336.